News About: Pharm. Industry


Loopholes of preferential sale approval system causes damages on pharmas

Loopholes of the preferential sale approval system, which was implemented to shorten times to commercialize generics drugs by nullifying an original product’s patent, have caused delays for generics to be launched eve...

Kolon Life Science conducts overseas marketing services to attract foreign patients for ‘Invossa’

Kolon Life Science(CEO Woo-Seok Lee) announced on the 13th that the company signed a strategic MOU for Invossa K Inj to attract foreign patients with the Korea Medical Tourism Promotion Association(President Chun-Ki J...

Pharmas extend rebate control to client distributors

While the pharmaceutical industry has recently had rebate issues once again, individual pharmaceutical companies are tightening their own rules to eradicate rebates. They have only performed a program to eradicate re...

Daewoong Pharmaceutical acquires preferential sale right in KRW 150 billion hepatitis B generic market

Daewoong Pharmaceutical will enter the market of ‘tenofovir,’ a hepatitis B treatment, worth of approximately KRW 150 billion. Daewoong Pharmaceutical(CEO Jong-Wook Lee) announ...

Tonymoly gives up acquisition of Tai Guk Pharm, largest dermatologic product company

Tonymoly, a cosmetic brand, gave an official notice to acquire Tai Guk Pharm(decided to acquire 5.826 million shares, KRW 14 billion), the Korea’s largest pharmaceutical company specializing in dermatologic products, ...

Seoul Western DPO considers to start clinic S’s rebate investigation

The pharmaceutical field is getting nervous as the Seoul Western District Prosecutor’s Office(Seoul Western DPO), which has been quiet over pharmaceutical companies’ rebates, have shown movements to start a rebate inv...

Dongwha Pharm-MSD Korea signs license agreement of antidepressant ‘Remeron’

Dongwha Pharm(CEO Ji-Hoon Sohn) signed a MSD’s exclusive sale and supply agreement of Remeron(generic name: mirtazapine), a MSD’s antidepressant, in Korea on the 8th of September. Remeron, a MSD’s NaSSA(antidepressan...

TissueGene receives a grand for ‘Invossa’ development from U.S. Maryland

TissueGene(CEO Bum-Seop Lee/Woo-Seok Lee) Co-CEO Woo-Seok Lee participated in a reception at Habib House, the U.S. Ambassador to South Korea’s residence in Seoul, hosted by officials the Maryland Department of Commerc...

The amount of listed pharmas’ foreigner-owned stocks appraised is KRW 3.8 trillion

The amount of listed pharmaceutical companies’ stocks owned by foreign investors was appraised KRW 3.8 billion. Yakup Shinmoon(www.yakup.com) analyzed the KOSPI and KOSDAQ listed pharmaceutical companies’ ratio of fo...

Celltrion’s biosimilar ‘Herzuma’ proven in equivalence of efficacy with original

At the European Society for Medical Oncology(ESMO) symposium on the 9th(local time) in Madrid, Spain, Celltrion announced additional clinical trial results of 1-year safety of Herzuma(development name: CT-P6), an anti...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.